지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2013.1
- 수록면
- 140 - 144 (5page)
이용수
초록· 키워드
오류제보하기
The presence of severe pulmonary arterial hypertension (PAH) in patients with atrial septal defect (ASD) is still thought to preclude shunt closure, although there are several reports of good clinical outcomes after vasodilator therapy. We report the case of a young woman with ASD and severe PAH who was able to successfully undergo percutaneous shunt closure following 1 year use of the oral endothelin receptor antagonist, bosentan.
목차
등록된 정보가 없습니다.
참고문헌 (12)
참고문헌 신청
Balint OH / 2008 / Outcomes in patients with pulmonary hypertension undergoing percutaneous atrial septal defect closure / Heart 94 : 1189 ~ 1193
Besterman E / 1961 / Atrial septal defect with pulmonary hypertension / Br Heart J 23 : 587 ~ 598
Diller GP / 2007 / Pulmonary vascular disease in adults with congenital heart disease / Circulation 115 : 1039 ~ 1050
Dimopoulos K / 2008 / Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy / Int
Galie N / 2006 / Bosentan Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) Investigators. Bosentan therapy in patients with Eisenmenger syndrome: a multicente
Besterman E / 1961 / Atrial septal defect with pulmonary hypertension / Br Heart J 23 : 587 ~ 598
Diller GP / 2007 / Pulmonary vascular disease in adults with congenital heart disease / Circulation 115 : 1039 ~ 1050
Dimopoulos K / 2008 / Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy / Int
Galie N / 2006 / Bosentan Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) Investigators. Bosentan therapy in patients with Eisenmenger syndrome: a multicente
이 논문의 저자 정보
최근 본 자료
댓글(0)
0